tiprankstipranks
Advertisement
Advertisement
SciSparc initiates SCI-110 clinical trial in Germany
PremiumThe FlySciSparc initiates SCI-110 clinical trial in Germany
17d ago
SciSparc Subsidiary NeuroThera Labs Closes Majority Acquisition of CliniQuantum
Premium
Company Announcements
SciSparc Subsidiary NeuroThera Labs Closes Majority Acquisition of CliniQuantum
2M ago
SciSparc Subsidiary Wins Conditional TSXV Nod for CliniQuantum Acquisition, Amends Deal Terms
Premium
Company Announcements
SciSparc Subsidiary Wins Conditional TSXV Nod for CliniQuantum Acquisition, Amends Deal Terms
2M ago
Clearmind Medicine announces Hong Kong patent filing for depression therapy
PremiumThe FlyClearmind Medicine announces Hong Kong patent filing for depression therapy
5M ago
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum
Premium
Company Announcements
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum
5M ago
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
Premium
The Fly
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
5M ago
SciSparc announces 1-for-9 reverse share split
PremiumThe FlySciSparc announces 1-for-9 reverse share split
5M ago
SciSparc to Enact 1-for-9 Reverse Share Split as Outstanding Shares Shrink
Premium
Company Announcements
SciSparc to Enact 1-for-9 Reverse Share Split as Outstanding Shares Shrink
5M ago
SciSparc announces 1-for-9 reverse share split
Premium
The Fly
SciSparc announces 1-for-9 reverse share split
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100